Neo-adjuvant Chemotherapy for Osteosarcoma of the Extremities: The Experience at the Rizzoli Institute in 210 Patients Treated with Two Successively Activated Preoperative Protocols Using High-Dose or Moderate-Dose Methotrexate + Cisplatin or High-Dose Methotrexate + Cisplatin + Doxorubicin
暂无分享,去创建一个
P. Picci | G. Bacci | M. Mercuri | M. Campanacci | M. Avella | A. B. D. Prever | A. Ferraro | P. Caldora | A. Mancini | F. Gherlinzoni | A. Ferruzzi | M. Fontana